Legrand: Statement of Transactions in Own Shares from April 12, 2021 to April 16, 2021
Tweet
Share
E-mailLIMOGES, France--(BUSINESS WIRE)-- Regulatory News:
Legrand (Paris: LR):
Aggregated presentation by day and by market
| Name of the issuer | Identity code of the Issuer | Day of the transaction | Identity code of the financial instrument |
Total daily volume (in number of shares) |
Daily weighted average purchase price of the shares* |
Market (MIC Code) |
| LEGRAND SA | 969500XXRPGD7HCAFA91 | 4/12/2021 | FR0010307819 |
25 494 |
82.49 |
XPAR |
LEGRAND SA |
969500XXRPGD7HCAFA91 |
4/13/2021 |
FR0010307819 |
31 732 |
83.15 |
XPAR |
LEGRAND SA |
969500XXRPGD7HCAFA91 |
4/14/2021 |
FR0010307819 |
47 000 |
82.21 |
XPAR |
LEGRAND SA |
969500XXRPGD7HCAFA91 |
4/15/2021 |
FR0010307819 |
30 905 |
82.79 |
XPAR |
LEGRAND SA |
969500XXRPGD7HCAFA91 |
4/16/2021 |
FR0010307819 |
11 233 |
82.79 |
XPAR |
* Rounded to two decimal places |
TOTAL |
146 364 |
82.63 |
|||
Société anonyme au capital de 1 069 790 984 euros
Siège social : 128, avenue du Maréchal de Lattre de Tassigny – 87000 Limoges
421 259 615 RCS Limoges
View source version on businesswire.com: https://www.businesswire.com/news/home/20210419005378/en/
Legrand
Source: Legrand
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jeff Blackburn Joins DoorDash Board of Directors
- NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine
- Park National Corporation reports financial results for first quarter 2024
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
